Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-20

Clinical Trial Update: Co-administration of IVM and ALB in School-based Deworming in Uganda

View source ↗

Summary

A completed clinical trial evaluated co-administration of ivermectin and albendazole for school-based deworming in Uganda.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albendazole (ALBENDAZOLE)
  • IVERMECTIN (Ivermectin)

Snippet

Sponsor: Jennifer Keiser | Conditions: Helminthiasis, Intestinal Worms | Status: COMPLETED